| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/17/2015 | US8956632 Alloplastic injectable dermal filler and methods of use thereof |
| 02/17/2015 | US8956630 Absorbent composition for surface treatment |
| 02/17/2015 | US8956629 Dental composition containing organic nanotube |
| 02/17/2015 | US8956627 Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates |
| 02/17/2015 | US8956617 Vaccination by transcutaneous targeting |
| 02/17/2015 | US8956603 Amphiphilic compounds and self-assembling compositions made therefrom |
| 02/17/2015 | US8956602 Delivery of drugs |
| 02/17/2015 | US8956600 Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 02/17/2015 | US8956598 Hydrocarbon mixtures and use thereof |
| 02/17/2015 | US8956572 Single use system for sterilely producing lipid-nucleic acid particles |
| 02/17/2015 | US8956545 Hollow microneedle having variable appearance and method for manufacturing the same |
| 02/17/2015 | US8955777 Method for producing salt dust and salt dust generator |
| 02/17/2015 | US8955512 Method of forming an aerosol for inhalation delivery |
| 02/17/2015 | CA2855309C Method for producing patch, patch and package |
| 02/17/2015 | CA2788777C Policosanol nanoparticles |
| 02/17/2015 | CA2748365C Pharmaceutical composition of lyophilized formulation and preparation method of the same |
| 02/17/2015 | CA2733823C Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue |
| 02/17/2015 | CA2695419C Compositions and methods for microbe storage and delivery |
| 02/17/2015 | CA2679782C Oral administration of a calcitonin |
| 02/17/2015 | CA2673976C Gel composition for treating mycosis |
| 02/17/2015 | CA2662209C Implantable devices for producing insulin |
| 02/17/2015 | CA2655509C Steroid-containing sustained release intraocular implants and related methods |
| 02/17/2015 | CA2635337C Device for treating the anal sphincter |
| 02/17/2015 | CA2616181C Pharmaceutical formulations/composition of guanfacine suitable for single dose form administration daily |
| 02/17/2015 | CA2615378C Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof |
| 02/17/2015 | CA2578784C Compositions containing alpha-2-adrenergic agonist components |
| 02/12/2015 | WO2015021390A2 Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis |
| 02/12/2015 | WO2015021382A2 Topical compositions and methods of using the same |
| 02/12/2015 | WO2015021153A1 Sustained release dosage forms for a jak1 inhibitor |
| 02/12/2015 | WO2015021031A1 Conformable patch pump |
| 02/12/2015 | WO2015020943A2 Digestive enzyme composition suitable for enteral administration |
| 02/12/2015 | WO2015020499A1 Composition for improving skin conditions comprising a fragment of human heat shock protein 90a as an active ingredient |
| 02/12/2015 | WO2015020286A1 Stable triple-layer capsule using poorly water-soluble substance, manufacturing method therefor and cosmetic composition using same |
| 02/12/2015 | WO2015020240A1 Entecavir microspheres and pharmaceutical composition for parenteral administration containing same |
| 02/12/2015 | WO2015020191A1 Calcium agent |
| 02/12/2015 | WO2015020186A1 Tablet composition |
| 02/12/2015 | WO2015020153A1 Beraprost-containing patch |
| 02/12/2015 | WO2015020139A1 Nanoparticles and nanoparticle composition, and method for producing nanoparticles and nonparticle composition |
| 02/12/2015 | WO2015020068A1 Ester polymer phosphate derivative and dispersant |
| 02/12/2015 | WO2015020026A1 Nucleic acid-encapsulating polymer micelle complex and method for producing same |
| 02/12/2015 | WO2015019307A1 Microcapsules containing probiotics and methods of making same |
| 02/12/2015 | WO2015019304A2 Continuous release compositions made from hyaluronic acid, and therapeutic applications of same |
| 02/12/2015 | WO2015019256A1 Pharmaceutical composition of vilazodone and processes of preparation thereof |
| 02/12/2015 | WO2015019246A1 Reducing reflux while sleeping by stimulating saliva with adhering troches |
| 02/12/2015 | WO2015019237A1 Pharmaceutical composition of vilazodone |
| 02/12/2015 | WO2015019211A1 Delivery system for active agents |
| 02/12/2015 | WO2015018800A1 Inhalable particles comprising tiotropium and indacaterol |
| 02/12/2015 | WO2015018794A1 A pharmaceutical composition containing ropinirole hcl administrable by oral route, and manufacturing method thereof |
| 02/12/2015 | WO2015018461A1 Therapeutic compositions comprising hyaluronic acid |
| 02/12/2015 | WO2015018344A1 Application of andrographolide in the preparation of a pharmaceutical for treatment of inflammatory bowel disease, andrographolide enteric targeting micropellet, and method for preparation thereof |
| 02/12/2015 | WO2015018343A1 Medicine composition for wound therapy |
| 02/12/2015 | WO2015018129A1 Antihypertensive chinese medicine preparation and preparation method therefor |
| 02/12/2015 | WO2015018128A1 Hypoglycemic chinese medicine preparation and preparation method therefor |
| 02/12/2015 | WO2015018127A1 Hypolipidemic chinese medicine preparation and preparation method therefor |
| 02/12/2015 | WO2015018125A1 Traditional chinese medicine preparation for reducing blood lipid and preparation method thereof |
| 02/12/2015 | WO2015018124A1 Traditional chinese medicine preparation for reducing blood pressure and preparation method thereof |
| 02/12/2015 | WO2015018123A1 Traditional chinese medicine preparation for reducing blood sugar and preparation method thereof |
| 02/12/2015 | US20150045764 Silk reservoirs for drug delivery |
| 02/12/2015 | US20150045749 Percutaneous absorption preparation containing donepezil, and method for preparing same |
| 02/12/2015 | US20150045748 Transdermal device including porous microparticles |
| 02/12/2015 | US20150045453 Emulsified food product composition |
| 02/12/2015 | US20150045452 Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose |
| 02/12/2015 | US20150045450 Nanoparticles of a metal and a nucleobase |
| 02/12/2015 | US20150045448 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045447 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045446 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045440 Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
| 02/12/2015 | US20150045439 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045438 Amantadine compositions and methods of use |
| 02/12/2015 | US20150045419 Reversibly crosslinked micelle systems |
| 02/12/2015 | US20150045403 Pharmaceutical Cream Compositions and Methods of Use |
| 02/12/2015 | US20150045388 Topical regional neuro-affective therapy |
| 02/12/2015 | US20150045383 Treating pain in patients with hepatic impairment |
| 02/12/2015 | US20150045353 Formulations containing gamma secretase modulators, methods for preparation and delivery thereof |
| 02/12/2015 | US20150045352 COMPOSITIONS CONTROLLING pH RANGE OF RELEASE AND/OR RELEASE RATE |
| 02/12/2015 | US20150045338 Methods for treating intrapulmonary infections |
| 02/12/2015 | US20150045337 Controlled release compositions and their methods of use |
| 02/12/2015 | US20150045336 Tazobactam and ceftolozane antibiotic compositions |
| 02/12/2015 | US20150045335 Vaginal inserted estradiol pharmaceutical compositons and methods |
| 02/12/2015 | US20150045333 Liquid compositions comprising vitamin d and uses thereof |
| 02/12/2015 | US20150045321 Hyaluronic acid based formulations |
| 02/12/2015 | US20150045315 Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound |
| 02/12/2015 | US20150045309 Cyclosporin emulsions |
| 02/12/2015 | US20150045301 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases |
| 02/12/2015 | US20150045296 Method for treating diabetic retinopathy |
| 02/12/2015 | US20150045282 Compositions containing delta-9-thc-amino acid esters and process of preparation |
| 02/12/2015 | US20150044314 Pomegranate Oil For Preventing And Treating Neurodegenerative Diseases |
| 02/12/2015 | US20150044310 Use of radix salviae miltiorrhizae (danshen) or its preparations in preparation of drugs for treating diseases related to hepatic fibrosis |
| 02/12/2015 | US20150044305 Inhalation of nitric oxide for treating respiratory diseases |
| 02/12/2015 | US20150044303 Pharmaceutical Formulations Useful for Inhibiting Acid Secretion and Methods for Making and Using Them |
| 02/12/2015 | US20150044302 Compositions and methods for promoting appetite suppression using alkali metals |
| 02/12/2015 | US20150044299 Oxygenated Antimicrobial Topical Composition |
| 02/12/2015 | US20150044297 Novel galenical system for active transport, method for preparation and use |
| 02/12/2015 | US20150044296 Combination therapy to improve joint, tendon, and ligament healing |
| 02/12/2015 | US20150044295 Combination Product Comprising Phentermine and Topiramate, and Preparation Method Thereof |
| 02/12/2015 | US20150044294 Enteric Coated Multiparticulate Composition With Proteinaceous Subcoat |
| 02/12/2015 | US20150044292 Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| 02/12/2015 | US20150044290 Treatment method using liquid food composition |
| 02/12/2015 | US20150044289 Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate |
| 02/12/2015 | US20150044288 Aerosol tyrosine kinase inhibitor compounds and uses thereof |